These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 26630904)

  • 1. Editorial. Role of Drug Transport and Pharmacokinetics in Drug Efficacy and Safety Part 1.
    Liu C; He X
    Curr Drug Metab; 2015; 16(9):730-1. PubMed ID: 26630904
    [No Abstract]   [Full Text] [Related]  

  • 2. Emerging in vitro tools to evaluate cytochrome P450 and transporter-mediated drug-drug interactions.
    Lu C; Liao M; Cohen L; Xia CQ
    Curr Drug Discov Technol; 2010 Sep; 7(3):199-222. PubMed ID: 20843292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease-Associated Changes in Drug Transporters May Impact the Pharmacokinetics and/or Toxicity of Drugs: A White Paper From the International Transporter Consortium.
    Evers R; Piquette-Miller M; Polli JW; Russel FGM; Sprowl JA; Tohyama K; Ware JA; de Wildt SN; Xie W; Brouwer KLR;
    Clin Pharmacol Ther; 2018 Nov; 104(5):900-915. PubMed ID: 29756222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug trafficking: recent advances in therapeutics and disease.
    Sprowl JA; Sparreboom A
    Clin Pharmacol Ther; 2012 Nov; 92(5):531-4. PubMed ID: 23085872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Considerations in the design and development of transport inhibitors as adjuncts to drug therapy.
    Dantzig AH; de Alwis DP; Burgess M
    Adv Drug Deliv Rev; 2003 Jan; 55(1):133-50. PubMed ID: 12535578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intestinal absorption and renal excretion mediated by transporters and the relationship with drug-drug interaction].
    Zhang J; Liu KX
    Yao Xue Xue Bao; 2010 Sep; 45(9):1089-94. PubMed ID: 21351563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies to Reduce Solute Carrier-Mediated Toxicity.
    Hu S; Sprowl JA
    Clin Pharmacol Ther; 2018 Nov; 104(5):799-802. PubMed ID: 30028006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Drug Transporters on Pharmacological Responses and Safety.
    Liu CX; Yi XL; Fan HR; Wu WD; Zhang X; Xiao XF; He X
    Curr Drug Metab; 2015; 16(9):732-52. PubMed ID: 26630905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of Transporter Polymorphisms on Drug Disposition and Response: A Perspective From the International Transporter Consortium.
    Yee SW; Brackman DJ; Ennis EA; Sugiyama Y; Kamdem LK; Blanchard R; Galetin A; Zhang L; Giacomini KM
    Clin Pharmacol Ther; 2018 Nov; 104(5):803-817. PubMed ID: 29679469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational modeling to accelerate the identification of substrates and inhibitors for transporters that affect drug disposition.
    Ekins S; Polli JE; Swaan PW; Wright SH
    Clin Pharmacol Ther; 2012 Nov; 92(5):661-5. PubMed ID: 23010651
    [No Abstract]   [Full Text] [Related]  

  • 11. Editorial: Role of Drug Metabolism and its Mediated DDI in Drug Efficacy and Safety Part 2.
    Liu C; He X
    Curr Drug Metab; 2015; 16(10):848-9. PubMed ID: 26652253
    [No Abstract]   [Full Text] [Related]  

  • 12. Imaging in the study of membrane transporters.
    Kusuhara H
    Clin Pharmacol Ther; 2013 Jul; 94(1):33-6. PubMed ID: 23615038
    [No Abstract]   [Full Text] [Related]  

  • 13. Roles of Renal Drug Transporter in Drug Disposition and Renal Toxicity.
    Yang X; Han L
    Adv Exp Med Biol; 2019; 1141():341-360. PubMed ID: 31571169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Silico Meets In
    Kar S; Chatterjee S
    Curr Drug Metab; 2021; 22(7):502. PubMed ID: 34525918
    [No Abstract]   [Full Text] [Related]  

  • 15. ITC recommendations for transporter kinetic parameter estimation and translational modeling of transport-mediated PK and DDIs in humans.
    Zamek-Gliszczynski MJ; Lee CA; Poirier A; Bentz J; Chu X; Ellens H; Ishikawa T; Jamei M; Kalvass JC; Nagar S; Pang KS; Korzekwa K; Swaan PW; Taub ME; Zhao P; Galetin A;
    Clin Pharmacol Ther; 2013 Jul; 94(1):64-79. PubMed ID: 23588311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular drug concentrations and transporters: measurement, modeling, and implications for the liver.
    Chu X; Korzekwa K; Elsby R; Fenner K; Galetin A; Lai Y; Matsson P; Moss A; Nagar S; Rosania GR; Bai JP; Polli JW; Sugiyama Y; Brouwer KL;
    Clin Pharmacol Ther; 2013 Jul; 94(1):126-41. PubMed ID: 23588320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug transporters in pharmacokinetics.
    Petzinger E; Geyer J
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Mar; 372(6):465-75. PubMed ID: 16532306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why clinical modulation of efflux transport at the human blood-brain barrier is unlikely: the ITC evidence-based position.
    Kalvass JC; Polli JW; Bourdet DL; Feng B; Huang SM; Liu X; Smith QR; Zhang LK; Zamek-Gliszczynski MJ;
    Clin Pharmacol Ther; 2013 Jul; 94(1):80-94. PubMed ID: 23588303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacokinetics in the drug regulatory process.
    Salmonson T; Rane A
    Clin Pharmacokinet; 1990 Mar; 18(3):177-83. PubMed ID: 2323153
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of membrane transporters in the safety profile of drugs.
    Lee EJ; Lean CB; Limenta LM
    Expert Opin Drug Metab Toxicol; 2009 Nov; 5(11):1369-83. PubMed ID: 19663740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.